Literature DB >> 27245301

High resolution ion chamber array delivery quality assurance for robotic radiosurgery: Commissioning and validation.

Oliver Blanck1, Laura Masi2, Mark K H Chan3, Sebastian Adamczyk4, Christian Albrecht5, Marie-Christin Damme6, Britta Loutfi-Krauss7, Manfred Alraun5, Roman Fehr8, Ulla Ramm7, Frank-Andre Siebert9, Tenzin Sonam Stelljes10, Daniela Poppinga10, Björn Poppe10.   

Abstract

PURPOSE: High precision radiosurgery demands comprehensive delivery-quality-assurance techniques. The use of a liquid-filled ion-chamber-array for robotic-radiosurgery delivery-quality-assurance was investigated and validated using several test scenarios and routine patient plans. METHODS AND MATERIAL: Preliminary evaluation consisted of beam profile validation and analysis of source-detector-distance and beam-incidence-angle response dependence. The delivery-quality-assurance analysis is performed in four steps: (1) Array-to-plan registration, (2) Evaluation with standard Gamma-Index criteria (local-dose-difference⩽2%, distance-to-agreement⩽2mm, pass-rate⩾90%), (3) Dose profile alignment and dose distribution shift until maximum pass-rate is found, and (4) Final evaluation with 1mm distance-to-agreement criterion. Test scenarios consisted of intended phantom misalignments, dose miscalibrations, and undelivered Monitor Units. Preliminary method validation was performed on 55 clinical plans in five institutions.
RESULTS: The 1000SRS profile measurements showed sufficient agreement compared with a microDiamond detector for all collimator sizes. The relative response changes can be up to 2.2% per 10cm source-detector-distance change, but remains within 1% for the clinically relevant source-detector-distance range. Planned and measured dose under different beam-incidence-angles showed deviations below 1% for angles between 0° and 80°. Small-intended errors were detected by 1mm distance-to-agreement criterion while 2mm criteria failed to reveal some of these deviations. All analyzed delivery-quality-assurance clinical patient plans were within our tight tolerance criteria.
CONCLUSION: We demonstrated that a high-resolution liquid-filled ion-chamber-array can be suitable for robotic radiosurgery delivery-quality-assurance and that small errors can be detected with tight distance-to-agreement criterion. Further improvement may come from beam specific correction for incidence angle and source-detector-distance response.
Copyright © 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CyberKnife robotic radiosurgery; Delivery quality assurance; Liquid filled MicroLion ion chamber array; Stereotactic body radiation therapy

Mesh:

Year:  2016        PMID: 27245301     DOI: 10.1016/j.ejmp.2016.05.060

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  5 in total

1.  Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy.

Authors:  Tobias Gauer; Thilo Sothmann; Oliver Blanck; Cordula Petersen; René Werner
Journal:  Strahlenther Onkol       Date:  2018-02-15       Impact factor: 3.621

2.  Two-dimensional solid-state array detectors: A technique for in vivo dose verification in a variable effective area.

Authors:  Kananan Utitsarn; Giordano Biasi; Nauljun Stansook; Ziyad A Alrowaili; Marco Petasecca; Martin Carolan; Vladimir L Perevertaylo; Wolfgang A Tomé; Tomas Kron; Michael L F Lerch; Anatoly B Rosenfeld
Journal:  J Appl Clin Med Phys       Date:  2019-10-14       Impact factor: 2.102

3.  Assessment of Delivery Quality Assurance for Stereotactic Radiosurgery With Cyberknife.

Authors:  Jun Li; Xile Zhang; Yuxi Pan; Hongqing Zhuang; Junjie Wang; Ruijie Yang
Journal:  Front Oncol       Date:  2021-11-17       Impact factor: 6.244

4.  CyberKnife® fixed cone and Iris™ defined small radiation fields: Assessment with a high-resolution solid-state detector array.

Authors:  Giordano Biasi; Marco Petasecca; Susanna Guatelli; Ebert A Martin; Garry Grogan; Benjamin Hug; Jonathan Lane; Vladimir Perevertaylo; Tomas Kron; Anatoly B Rosenfeld
Journal:  J Appl Clin Med Phys       Date:  2018-07-12       Impact factor: 2.102

5.  Commissioning and clinical implementation of the first commercial independent Monte Carlo 3D dose calculation to replace CyberKnife M6™ patient-specific QA measurements.

Authors:  Maaike T W Milder; Markus Alber; Matthias Söhn; Mischa S Hoogeman
Journal:  J Appl Clin Med Phys       Date:  2020-10-25       Impact factor: 2.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.